Seattle biotech company RareCyte raises $20M to accelerate product development June 30, 2024 tech admin 1 Comment The funding adds to a $22 million round the company raised in 2019. Source link Previous Post Extreme E is now Extreme H, a hydrogen-powered racing series starting 2025 Next Post ‘Lab-grown’ meat maker hosts Miami tasting party as Florida ban goes into effect
The funding adds to a $22 million round the company raised in 2019.
The funding adds to a $22 million round the company raised in 2019.
I don’t think the title of your article matches the content lol. Just kidding, mainly because I had some doubts after reading the article.